GeneQuantum Healthcare

GeneQuantum Healthcare Overview

Founded 2013
Status Private
Latest Deal Type Later Stage VC
Latest Deal Amount $14.9M
Latest Deal Amount
Investors 3

GeneQuantum Healthcare General Information


Provider of technology designed to develop bio-therapeutics. The company's technology uses a ligase dependent conjugation platform that has opened a drastically enlarged therapeutic window, enabling researchers to focus on developing series of anti-tumor Antibody-Drug-Conjugates (ADCs).

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Suzhou Industrial Park
  • Suzhou, Jiangsu
  • China

GeneQuantum Healthcare Timeline

Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GeneQuantum Healthcare Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 08-May-2019 $14.9M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 27-Mar-2017 00.00 00.00 Completed Startup

GeneQuantum Healthcare Executive Team (1)

Name Title Board Seat Contact Info
Gang Qin Chief Executive Officer & Founder

GeneQuantum Healthcare Investors (3)

To view GeneQuantum Healthcare‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Huagai Capital Venture Capital Minority 000 0000 000000 0
Oriza Seed Capital Corporate Venture Capital Minority 000 0000 000000 0
TF Capital Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial